NuvemRx Acquires par8o from R1 RCM
February 2, 2026
NuvemRx, a tech-enabled pharmacy solutions provider for community health organizations, has acquired the 340B referral capture business par8o from R1 RCM. The deal adds par8o's referral technology and pharmacy integrations to NuvemRx's suite, expanding its specialty care coordination and 340B referral-capture capabilities to support more than 800 covered entities.
- Buyers
- NuvemRx
- Targets
- par8o
- Sellers
- R1 RCM
- Industry
- Healthcare Services
- Location
- Georgia, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Cloudmed Acquires par8o to Enhance 340B Discovery and Referral Management
December 15, 2021
Healthcare Services
Cloudmed has acquired par8o, a healthcare technology company specializing in 340B and patient referral management, to advance Cloudmed's 340B Discovery services and integrate par8o's machine learning into the CloudmedAI platform. The deal expands Cloudmed's capabilities to capture prescriptions from referrals and further automates referral-to-prescription matching across EMRs, pharmacies and specialists.
-
CorroHealth Acquires ParaRev
May 18, 2022
Healthcare Services
CorroHealth, a Carlyle-backed provider of clinically led revenue cycle management (RCM) solutions, has acquired ParaRev, a Chicago-based leader in accounts receivable recovery previously backed by Housatonic Partners. The deal (an add-on to the CorroHealth platform) expands CorroHealth's targeted RCM capabilities, including denial recovery and zero-balance underpayment recovery.
-
CareCloud Acquires RevNu Medical Management
April 2, 2025
Healthcare Services
CareCloud, Inc. (Nasdaq: CCLD) has acquired RevNu Medical Management, an audiology-focused revenue cycle management (RCM) provider based in Westminster, California. The acquisition expands CareCloud's specialty RCM capabilities and market presence in the hearing healthcare/audiology segment and will be integrated into a new hearing healthcare division led by RevNu's former CEO.
-
Acino Acquires M8 Pharmaceuticals
September 20, 2023
Pharmaceuticals
Swiss pharmaceutical company Acino has agreed to acquire M8 Pharmaceuticals, a Mexico City–headquartered specialty biopharmaceutical company and Montreux Growth Partners portfolio company. The deal brings over 300 M8 employees, an established product portfolio and pipeline, and market access in Mexico and Brazil to expand Acino's footprint and capabilities across Latin America; the transaction is expected to close by the end of 2023 subject to customary approvals.
-
R1 RCM Acquires Cloudmed
June 21, 2022
Healthcare Services
R1 RCM Inc. completed its acquisition of Cloudmed, combining two leading revenue cycle management (RCM) businesses to deliver an integrated, technology-driven platform for healthcare providers. The deal brings Cloudmed's data-driven RCM solutions and client base into R1's operations to expand capabilities and accelerate digital transformation across hospitals, health systems, and physician groups.
-
Elevance Health Acquires Paragon Healthcare
March 11, 2024
Healthcare Services
Elevance Health has closed its acquisition of Plano, Texas–based Paragon Healthcare, an infusion services and drug therapy provider operating more than 40 ambulatory infusion centers and serving over 35,000 patients. Paragon will operate under Elevance’s CarelonRx pharmacy services segment to expand access to specialty medications and scale infusion capabilities; financial terms were not disclosed (Axios reported the purchase may exceed $1 billion).
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.